Recent News

By Category: Countermeasures

Researchers describe first ‘functional HIV cure’ in an infant

(EurekAlert) A team of researchers from Johns Hopkins Children’s Center, the University of Mississippi Medical Center and the University of Massachusetts Medical School describe the first case of a so-called “functional cure” in an HIV-infected infant. The finding, the investigators say, may help pave the way to eliminating HIV infection in children.

New Bioterrorism Vaccine Gets First Test In Humans

(TheHerald) This trial, marking the first time a superantigen vaccine has been administered to humans, is designed to enroll 28 individuals. STEBVax is a proprietary, rationally designed and attenuated form of Staphylococcal Enterotoxin B (SEB), a member of a group of toxins called superantigens due to the ability to cause a massive inflammatory response leading  Read More »

Universal Influenza Antiviral Breakthrough

(GlobalBiodefense) Scientists from Australia’s Commonwealth Scientific and Industrial Research Organization (CSIRO) have helped to design a new drug to safeguard against epidemic and pandemic flu strains. The new antiviral agent has been proven to be effective in preventing the spread of different strains of influenza in laboratory models – including resistant strains of the virus.

America Is Not Prepared For A Pandemic Or Bioterrorism Disaster

(TheInquisitr) A new pandemic study maintains that the majority of schools and businesses in the United States are not prepared for such a disaster. The St. Louis University study addressed both response preparedness for bioterrorism attacks and pandemics spurred by infectious disease.

Cure in sight for kissing bug’s bite

(EurekAlert) Chagas disease, a deadly tropical infection caused by the protozoan parasite Trypanosoma cruzi and transmitted by biting insects called “kissing bugs,” has begun to spread around the world, including the U.S. Yet current treatment is toxic and limited to the acute stage. In The Journal of Infectious Diseases (JID), Galina Lepesheva, Ph.D., and her  Read More »